Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1126

JNJ372-Met-hIgG1

Home » JNJ372-Met-hIgG1

Background of JNJ372-Met-hIgG1

JNJ372-Met-hlgG1, a high affinity-specific humanized IgG1 antibody against HGFR. HGFR also known as the only high affinity receptor for hepatocyte growth factor,plays vital physiological functions during embryogenesis, angiogenesis, and repair processes.Under malignant conditions, the interaction between HGF and cMET triggers an intricate system of downstream mitogen-activated protein kinase (MAPK)/ERK and PI3K/AKT signaling cascades, thus resulting in uncontrolled cell proliferation, epithelial‐ mesenchymal transition (EMT) and metastatic spread. Antibodies to HGFR are used in humans as targeted therapies for a variety of cancers that included patients with bladder cancer,hepatocellular cancer and nonsmall cell lung cancer.

Specifications

Catalog Number:
KB-1126
Antibody Name:
JNJ372-Met-hIgG1
Isotype:
Human IgG1,kappa
FC Muations:
Wild Type
Target:
MET
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA|FACS|KD
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Wang Siyun,Ma Haiqing,Yan Yan et al. cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP.[J] J Cell Physiol, 2021, 236: 3963-3978.
  2. Maroun,C.R.,& Rowlands,T. The Met receptor tyrosine kinase: A key player in oncogenesis and drug resistance.[J] Pharmacology and Therapeutics,2014,142(3), 316-338.